Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Study on the Safety and Effects of AZD7789 for Patients with Relapsed ...
AZD7789 for Relapsed or Refractory Classical Hodgkin's Lymphoma ...
AZD7789 in NSCLC: safety, efficacy, and ongoing evaluation - VJOncology
阿斯利康:PD1/TIM3双抗报临床！国内仅1家布局 引言2022年5月24日，药审中心承办了 阿斯利康 的1类生物制品AZD7789的临床 ...
阿斯利康AZD7789新适应症获批临床，能否带领PD-1/TIM-3双抗走向成功？|肿瘤_新浪财经_新浪网
(PDF) 461 Generation of AZD7789, a novel PD-1 and TIM-3 targeting ...
阿斯利康：PD1/TIM3双抗报临床！国内仅1家布局 - 知乎
Phase II Evaluation of AZD7789, AZD0901, and Rilvegostomig in ...
免疫治療新進展！肺癌新藥AZD7789注射劑臨床！中外聯合開展! - 資訊咖
集中火力抗肿瘤！最新16款1类新药获批临床，阿斯利康、齐鲁在内 12月6日，据CDE官网，16款（治疗用生物制品10款，化药6款）1类新药获批 ...
PD1/TIM3双抗：阿斯利康报临床！国内仅1家布局_摩熵医药(原药融云)
Novel bispecific antibody-drug conjugate targeting PD-L1 and B7-H3 ...
速递！阿斯利康抗PD-1/TIM-3双抗在中国获批临床
Frontiers | PD-1/LAG-3 bispecific antibody potentiates T cell ...
KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3 ...
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and ...
Deciphering molecular and cellular ex vivo responses to bispecific ...
阿斯利康 TIM-3/PD1 双抗国内又一项临床获批_Insight_数据库_全球
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is ...
Anti-PD-1 triggers TIM-3 expression on CD8+ TILs in a TNF-dependent ...
Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in ...
Immune checkpoint TIM-3 in tumor immunotherapy: Immune checkpoint TIM-3 ...
Full article: Adaptive resistance to anti-PD1 therapy by Tim-3 ...
Sequential administration of anti-PD-1 and anti-Tim-3 antibodies ...
| Characteristics of the anti-PD-1 monoclonal antibody used in this ...
Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab ...
(PDF) Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
CD279 (PD-1) Monoclonal Antibody (eBioJ105 (J105)), eBioscience ...
Frontiers | Dual function antibody targeting αvβ3 and PD-L1 provide a ...
Frontiers | The bispecific antibody targeting VISTA and PD-L1 shows ...
A Novel Recombinant Fusion Protein with Soluble PD-1 and TIM-3 Domains ...
AZD1775 and anti-PD-1 antibody synergistically sensitize hepatoma to ...
sonesitatug vedotin (AZD0901) / Keymed Biosciences, Lepu Med, AstraZeneca
抗体药物-PD-1&TIM-3-新闻资讯-德泰生物
Full article: Advances in the structural characterization of complexes ...
Targeting PI3Kβ alone and in combination with chemotherapy or ...
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap ...
Full article: A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 ...
A bispecific antibody targeting HER2 and PD-L1 inhibits tumor growth ...
A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti ...
(PDF) A BIVALENT TIM-3/PD-1 BISPECIFIC ANTIBODY FOR THE TREATMENT OF PD ...
Characterization of immune responses to anti-PD-1 mono and combination ...
Bispecific Antibody Platform | Kyinno Bio
Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade ...
Expression of TIM3-related molecules in post-anti-PD-1 therapy samples ...
Table 1 from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell ...
CD279 (PD-1) Monoclonal Antibody (J43), PE, eBioscience™ | Invitrogen ...
Bispecific Antibodies in Cancer Immunotherapy - FineTest ELISA Kit ...
Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab - PMC
(PDF) Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion ...
Frontiers | Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor ...
Molecular structures of (A) PD-1 antigen (PDB: 3RRQ) [44] and (B) TIM-3 ...
1397 ATG 027 a first in class B7 H3 PD L1 bispecific antibody shows ...
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co ...
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 ...
Frontiers | Combination of GD2-directed bispecific trifunctional ...
A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral ...
Synergistic efficacy of PI3Kδ inhibitor with anti-PD-1 mAbs in immune ...
Antibody-drug Conjugate Information | ADCdb
PD-1 (CD279) (Tislelizumab Biosimilar) Recombinant Humanized mouse ...
Bispecific Antibodies for the Treatment of Cancer | Athena Publishing
News
724789-18-8_724789-18-8CAS号:724789-18-8/724789-18-8中英文名/分子式/结构式 – 960化工网
CD279 (PD-1) Antibody, Super Bright™ 702 (67-2799-42)
Development of a bispecific antibody targeting PD-L1 and TIGIT with ...
The enhanced antitumor activity of bispecific antibody targeting PD-1 ...
Full article: Combination of two novel blocking antibodies, anti-PD-1 ...
怎样选择体内用anti-PD-1抗体？
重磅！阿斯利康血液肿瘤创新药，显著降低死亡风险 ELEVATE TN III期临床试验的完整结果显示，在接受Calquence与 ...
Chinese Medical Journal
Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer ...
Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior ...
PD1抗体[EPR20665] (ab214421)| Abcam中文官网
Changing Practice in NSCLC: Should We Optimize Immunotherapy Responses ...
Anti-PD-1 antibody armored γδ T cells enhance anti-tumor efficacy in ...
CD279 (PD-1) Monoclonal Antibody (J43), FITC, eBioscience™ | Invitrogen ...
CD279 (PD-1) Monoclonal Antibody (MIH4), eBioscience™ | Invitrogen (14 ...
Full article: A strategy for the efficient construction of anti-PD1 ...
Anti-PD1 antibody [RM1033] Rabbit multiclonal (ab309363) | Abcam
A Bifunctional Anti-PD-1/TGF-β Fusion Antibody Restores Antitumour ...
